Amicus Therapeutics, Inc (FOLD) Stock Price, Quote & AI Analysis

Live FOLD stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Amicus Therapeutics, Inc.

TradeVae provides AI-driven analysis and real-time market intelligence for Amicus Therapeutics, Inc (FOLD), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

FOLD
Amicus Therapeutics, Inc
real-time
$0.00 +0.00 (+0.00%)
Market Cap
$4,549,870,316.88
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Jul 29, 2026 Q2
Market
EPS Estimate: $0.0825
Revenue Estimate: $185,811,615.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Amicus Therapeutics, Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Amicus Therapeutics, Inc Overview

Company information

Company Overview

Company description not available

Company Details
Market Cap
$4.55B
Weighted Shares Outstanding
314,000,712
Address
47 HULFISH STREET, PRINCETON, NJ, 08542
Employees
511
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Amicus Therapeutics, Inc Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...